Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).

NCT06603753 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-09-19

No results posted yet for this study

Summary

The aim of this study is to evaluate serum bilirubin/albumin (B/A) ratio compared to total serum bilirubin (TSB) for early prediction of bilirubin-induced neurological dysfunction (BIND).

Conditions

  • Hyperbilirubinemia, Neonatal

Sponsors & Collaborators

  • alaa aboelhassan mohamed aboelhassan

    lead OTHER

Principal Investigators

  • Mahmoud A Ahmed, Dr · Assiut University

  • Jaafar I Mohamad, Prof · Assiut University

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-01-01
Completion
2026-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06603753 on ClinicalTrials.gov